The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Immunocore Holdings plc(NASDAQ:IMCR) 
Immunocore Holdings plc, a late-stage biotechnology company, develops immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. The company's lead oncology therapeutic candidate is tebentafusp, which is in a randomized Phase 3 clinical trial in patients with previously untr...
Share this website to your friends
Immunocore plc Days Payable Outstanding ttm (DPO)
Immunocore plc Days Receivable Outstanding ttm (DSO)
Immunocore plc Days Inventory Outstanding ttm (DIO)
Immunocore plc Op Cashflow Per Share ttm
Immunocore plc Free Cashflow Per Share ttm
Immunocore plc Cash Per Share ttm
Immunocore plc P/S ratio ttm
Immunocore plc (GAAP) P/E ratio ttm
Immunocore plc P/B ratio ttm
No extra charts and metrics for this ticker.